104 related articles for article (PubMed ID: 21241281)
41. Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant.
Hale KA; Shaw PJ; Dalla-Pozza L; MacIntyre CR; Isaacs D; Sorrell TC
Br J Haematol; 2010 Apr; 149(2):263-72. PubMed ID: 20096013
[TBL] [Abstract][Full Text] [Related]
42. Outcome of allogeneic hematopoietic stem cell transplantation for children with acute myelogenous leukemia in second complete remission: single center experience.
Ishaqi MK; Afzal S; Dupuis A; Doyle J; Gassas A
Pediatr Transplant; 2009 Dec; 13(8):999-1003. PubMed ID: 19032410
[TBL] [Abstract][Full Text] [Related]
43. Acute myeloid and lymphoblastic leukemia in adults. The course of the disease in 315 patients from one region, during a ten-year period.
Johnsen HE; Bergmann OJ; Ellegaard J; Bastrup-Madsen P
Dan Med Bull; 1989 Apr; 36(2):189-93. PubMed ID: 2707057
[TBL] [Abstract][Full Text] [Related]
44. The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen.
Ayas M; Al-Seraihi A; Al-Mahr M; Al-Jefri A; Belgaumi A; Elhassan I; El-Solh H
Pediatr Blood Cancer; 2006 Dec; 47(7):926-30. PubMed ID: 16425264
[TBL] [Abstract][Full Text] [Related]
45. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
[TBL] [Abstract][Full Text] [Related]
46. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
47. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
[TBL] [Abstract][Full Text] [Related]
48. Treatment of relapsed acute myelogeneous leukaemia with MLL/AF 6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy.
Schuster FR; Führer M; Woessmann W; Reiter A; Harbott J; Viehmann S; Borkhardt A
Leukemia; 2005 Jul; 19(7):1273-4; author reply 1275-6. PubMed ID: 15902291
[No Abstract] [Full Text] [Related]
49. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
[TBL] [Abstract][Full Text] [Related]
50. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
[No Abstract] [Full Text] [Related]
51. Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemia.
Løhmann DJA; Asdahl PH; Abrahamsson J; Ha SY; Jónsson ÓG; Kaspers GJL; Koskenvuo M; Lausen B; De Moerloose B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2018 Sep; 65(9):e27231. PubMed ID: 29781563
[TBL] [Abstract][Full Text] [Related]
52. The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.
Foresto SA; Youlden DR; Baade PD; Hallahan AR; Aitken JF; Moore AS
Pediatr Blood Cancer; 2015 Sep; 62(9):1664-6. PubMed ID: 25855531
[TBL] [Abstract][Full Text] [Related]
53. Invasive fungal infections in paediatric acute myeloid leukaemia.
Johnston DL; Lewis V; Yanofsky R; Gillmeister B; Ethier MC; Mitchell D; Cellot S; Dix D; Portwine C; Price V; Silva M; Zelcer S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Mycoses; 2013 Jul; 56(4):482-7. PubMed ID: 23437849
[TBL] [Abstract][Full Text] [Related]
54. Treatment-related mortality in children with acute myeloid leukaemia in Central America: incidence, timing and predictors.
Gupta S; Bonilla M; Valverde P; Fu L; Howard SC; Ribeiro RC; Sung L
Eur J Cancer; 2012 Jun; 48(9):1363-9. PubMed ID: 22082459
[TBL] [Abstract][Full Text] [Related]
55. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
Espersen ADL; Noren-Nyström U; Abrahamsson J; Ha SY; Pronk CJ; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Palmqvist L; Hasle H
Genes Chromosomes Cancer; 2018 Jul; 57(7):359-365. PubMed ID: 29569294
[TBL] [Abstract][Full Text] [Related]
56. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
Sung L; Aplenc R; Alonzo TA; Gerbing RB; Wang YC; Meshinchi S; Gamis AS
Int J Cancer; 2016 Nov; 139(9):1930-5. PubMed ID: 27312107
[TBL] [Abstract][Full Text] [Related]
57. Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.
Karlsson L; Cheuk D; De Moerloose B; Hasle H; Jahnukainen K; Juul-Dam KL; Kaspers G; Kovalova Z; Lausen B; Nyström UN; Palle J; Pronk CJ; Saks K; Tierens A; Zeller B; Abrahamsson J
Br J Haematol; 2023 May; 201(4):757-765. PubMed ID: 36762836
[TBL] [Abstract][Full Text] [Related]
58. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO).
Lie SO; Jonmundsson G; Mellander L; Siimes MA; Yssing M; Gustafsson G
Br J Haematol; 1996 Jul; 94(1):82-8. PubMed ID: 8757513
[TBL] [Abstract][Full Text] [Related]
59. Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group.
Klein K; van Litsenburg RRL; de Haas V; Dors N; van den Heuvel-Eibrink MM; Knops RRG; Tissing WJE; Versluys BA; Zwaan CM; Kaspers GJL
Pediatr Blood Cancer; 2020 Apr; 67(4):e28099. PubMed ID: 31872548
[TBL] [Abstract][Full Text] [Related]
60. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
